David Juurlink

Dr. Juurlink is a staff internist and head of the division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto. He is also a medical toxicologist at the Ontario Poison Centre at the Hospital for Sick Children and a scientist at the Institute for Clinical Evaluative Sciences.

He received degrees in Pharmacy (1990) and Medicine (1994) from Dalhousie University in Halifax, Nova Scotia, and completed postgraduate training in Internal Medicine (1998) followed by residency in Clinical Pharmacology (2000), a fellowship in Medical Toxicology (2002), and a PhD in Clinical Epidemiology (2003), all at the University of Toronto. He has received certification from the American Board of Internal Medicine, the American Board of Emergency Medicine (Medical Toxicology), and the American Board of Clinical Pharmacology.

He is presently the Sunnybrook site director for the program in Clinical Pharmacology & Toxicology and is actively involved with the Royal College of Physicians and Surgeons subspecialty program in Clinical Pharmacology and Toxicology as a member of the Nucleus committee and Vice Chair of the Examinations committee.

In addition to his clinical, teaching, and administrative activities, Dr. Juurlink maintains an active research program in the field of drug safety. His areas of particular interest include drug safety, adverse drug events, the consequences of drug-drug interactions in clinical practice, and the epidemiology of suicide and deliberate self-poisoning.

Download a Hi-Res Photo of David Juurlink

Commentaries by Dr. David Juurlink:

Facing some unpleasant truths about opioids // Regarder en face certaines vérités désagréables sur les opioids 
Canada slow to respond to prescription opioid crisis
 // Le Canada tarde à réagir à
la crise des opioïdes d’ordonnance
Prescription drug addiction is a major public health crisis

Podcasts by Dr. David Juurlink:

Understanding the opioids crisis in Canada

 

SaveSave


This work is licensed under a Creative Commons Attribution 4.0 International License.